Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Private Placement

Article summary

Bolt Biotherapeutics has acquired Prana Therapies in a stock-for-stock transaction and secured $120 million in concurrent private placement financing to extend its cash runway.